Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte and derived biosensor parameters

US9903831B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9903831-B2
Application numberUS-201214354387-A
CountryUS
Kind codeB2
Filing dateDec 28, 2012
Priority dateDec 29, 2011
Publication dateFeb 27, 2018
Grant dateFeb 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various embodiments for a method that allow for a more accurate analyte concentration with a biosensor by determining at least one physical characteristic, typically hematocrit, of the sample containing the analyte and deriving from this characteristic a parameter relating to the biosensor to attain accurate glucose concentration.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of determining an analyte concentration from a fluid sample with a biosensor having at least two electrodes and a reagent disposed on at least one of the electrodes, the method comprising: starting an analyte test sequence upon deposition of a sample on the biosensor; applying a first signal to the sample to determine a physical characteristic of the sample wherein the physical characteristic is hematocrit level; driving a second signal to the sample to cause a chemical transformation of the sample; measuring at least one output signal from the sample; obtaining a biosensor parametric factor from a look-up table or matrix based on the determined hematocrit level; and calculating an analyte concentration based on the biosensor parametric factor and the at least one output signal measured at one of a plurality of predetermined time positions from the start of the test sequence based on the relationship: G 1 = [ I E - P ⁢ ⁢ 1 P ⁢ ⁢ 2 * x 2 ] where G 1 is the analyte concentration; I E represents a total output signal of the electrodes of the biosensor measured at the one of the plurality of predetermined time positions; P 1 represents a known batch intercept of the biosensor; P 2 represents a known batch slope of the biosensor; and x 1 represents the biosensor parametric factor based on the determined hematocrit level of the sample; and annunciating the analyte concentration. 2. The method of claim 1 , in which the applying of the first signal and the driving of the second signal may be in sequential order. 3. The method of claim 1 , in which the applying of the first signal overlaps with the driving of the second signal. 4. The method of claim 1 , in which the applying of the first signal comprises directing an alternating signal to the sample so that the hematocrit level of the sample may be determined from an output of the alternating signal. 5. The method of claim 4 , in which the physical characteristic comprises an impedance characteristic representative of hematocrit level of the sample and the analyte comprises glucose. 6. The method of claim 5 , in which the applying of the first signal comprises including a step of driving first and second alternating signals at different respective frequencies in which a first frequency may be lower than the second frequency. 7. The method of claim 6 , in which the first frequency may be at least one order of magnitude lower than the second frequency. 8. The method of claim 7 , in which the first frequency comprises any frequency in the range of about 10 kHz to about 250 kHz. 9. The method of claim 1 , in which the one of the plurality of predetermined time positions for measuring at least one output signal during the test sequence may be about 2.5 seconds after a start of the test sequence. 10. The method of claim 9 , in which the one of the plurality of predetermined time positions comprises a time interval that overlaps a time point of 2.5 seconds after the start of the test sequence. 11. The method of claim 1 , in which another one of the plurality of predetermined time positions for measuring at least one output signal during the test sequence may be a time point of about 5 seconds after a start of the test sequence. 12. The method of claim 1 , in which one of the plurality of predetermined time positions comprises any time point at less than five seconds from a start of the test sequence. 13. The method of claim 12 , in which the another one of the plurality of predetermined time positions comprises any time point at less than ten seconds from a start of the test sequence. 14. The method of claim 13 , in which the one of the plurality of predetermined time positions comprises a time interval overlapping a time point of 2.5 seconds after the start of the test sequence and the another of the plurality of predetermined time positions comprises a time interval overlapping a time point of 5 seconds after the start of the test sequence. 15. The method of claim 1 , in which the at least two electrodes and at least two other electrodes are disposed in the same chamber provided on the substrate. 16. The method of claim 1 , in which the at least two electrodes comprise two electrodes to measure the hematocrit level and the analyte concentration. 17. The method of claim 1 , in which the at least two electrodes comprise a first set of at least two electrodes to determine the hematocrit level of the sample and a second set of at least two other electrodes to determine the analyte concentration. 18. The method of claim 17 , in which all of the electrodes are disposed on a same plane defined by a substrate of the biosensor. 19. The method of claim 16 , in which a third electrode may be disposed proximate the first set of at least two electrodes and connected to the second set of at least two other electrodes. 20. The system method of claim 18 , in which a reagent may be disposed proximate the second set of at least two other electrodes and no reagent may be disposed on the first set of at least two electrodes.

Assignees

Inventors

Classifications

  • Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels (optical biosensors G01N33/52) · CPC title

  • by investigating electrochemical variables; by using electrolysis or electrophoresis · CPC title

  • Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

  • G01N27/327Primary

    Biochemical electrodes {, e.g. electrical or mechanical details for in vitro measurements} · CPC title

  • ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9903831B2 cover?
Various embodiments for a method that allow for a more accurate analyte concentration with a biosensor by determining at least one physical characteristic, typically hematocrit, of the sample containing the analyte and deriving from this characteristic a parameter relating to the biosensor to attain accurate glucose concentration.
Who is the assignee on this patent?
Lifescan Scotland Ltd
What technology area does this patent fall under?
Primary CPC classification G01N27/3274. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).